Literature DB >> 22584774

Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis.

Ugo Nocentini1, Marco Bozzali, Barbara Spanò, Mara Cercignani, Laura Serra, Barbara Basile, Rosalba Mannu, Carlo Caltagirone, John De Luca.   

Abstract

Cognitive impairment may result in significant disability in patients with Multiple Sclerosis (MS). Previous Magnetic Resonance Imaging (MRI) studies on cognition in MS were mainly based on measures of gross brain involvement. This study, using voxel-based morphometry (VBM), aims to investigate associations between the regional distribution of grey matter (GM) damage and cognitive performance in patients with MS. Eighteen MS patients underwent an extensive neuropsychological battery and MRI, including T2-weighted scans and T1-weighted volumes. A group of 18 healthy individuals were also investigated by MRI and served as controls for the VBM. A cross-sectional analysis was first performed, to assess the pattern of regional GM atrophy in MS patients. Then, the impact of regional GM damage on patients' neuropsychological performance was investigated by multiple regression analyses in the patient group. Correlations between global indexes of brain damage and neuropsychological measures were also assessed for comparison with previous literature. The comparison between MS patients and healthy controls revealed a widespread pattern of regional GM atrophy. Consistent with previous studies, associations were found between neuropsychological scores, and global brain atrophy and T2-lesion volumes. Critically, significant associations were found between scores on the Symbol Digit Modalities test and Long Delay Cued Recall on the California Verbal Learning Test, and regional GM volumes in well localized areas of the prefrontal, parietal, temporal, and insular cortex. This study confirms that global assessments of brain damage correlate with measures of cognitive impairment in MS. Interestingly, VBM contributes to clarify those brain regions that more likely determine the cognitive deficits observed in patients. These findings clarify the pathophysiology of cognitive impairment in MS, and propose measures which could be considered for longitudinal monitoring of patients.

Entities:  

Mesh:

Year:  2014        PMID: 22584774     DOI: 10.1007/s11682-012-9170-7

Source DB:  PubMed          Journal:  Brain Imaging Behav        ISSN: 1931-7557            Impact factor:   3.978


  17 in total

Review 1.  Structural Image Analysis of the Brain in Neuropsychology Using Magnetic Resonance Imaging (MRI) Techniques.

Authors:  Erin D Bigler
Journal:  Neuropsychol Rev       Date:  2015-08-18       Impact factor: 7.444

Review 2.  Clinical relevance of brain volume measures in multiple sclerosis.

Authors:  Nicola De Stefano; Laura Airas; Nikolaos Grigoriadis; Heinrich P Mattle; Jonathan O'Riordan; Celia Oreja-Guevara; Finn Sellebjerg; Bruno Stankoff; Agata Walczak; Heinz Wiendl; Bernd C Kieseier
Journal:  CNS Drugs       Date:  2014-02       Impact factor: 5.749

3.  MR imaging and cognitive correlates of relapsing-remitting multiple sclerosis patients with cerebellar symptoms.

Authors:  Antonio Cerasa; Paola Valentino; Carmelina Chiriaco; Domenico Pirritano; Rita Nisticò; Cecilia M Gioia; Maria Trotta; Francesco Del Giudice; Tiziana Tallarico; Federico Rocca; Antonio Augimeri; Giacinta Bilotti; Aldo Quattrone
Journal:  J Neurol       Date:  2012-12-28       Impact factor: 4.849

4.  Cognitive impairment and structural brain changes in patients with clinically isolated syndrome at high risk for multiple sclerosis.

Authors:  Eva Hynčicová; Martin Vyhnálek; Adam Kalina; Lukáš Martinkovič; Tomáš Nikolai; Jiří Lisý; Jakub Hort; Eva Meluzínová; Jan Laczó
Journal:  J Neurol       Date:  2016-12-27       Impact factor: 4.849

5.  Sex differences in resting-state functional connectivity in multiple sclerosis.

Authors:  K A Koenig; M J Lowe; J Lin; K E Sakaie; L Stone; R A Bermel; E B Beall; S M Rao; B D Trapp; M D Phillips
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-27       Impact factor: 3.825

6.  Regional gray matter atrophy in relapsing remitting multiple sclerosis: baseline analysis of multi-center data.

Authors:  Sushmita Datta; Terrell D Staewen; Stacy S Cofield; Gary R Cutter; Fred D Lublin; Jerry S Wolinsky; Ponnada A Narayana
Journal:  Mult Scler Relat Disord       Date:  2015-01-17       Impact factor: 4.339

7.  The association between intra- and juxta-cortical pathology and cognitive impairment in multiple sclerosis by quantitative T2* mapping at 7 T MRI.

Authors:  Céline Louapre; Sindhuja T Govindarajan; Costanza Giannì; Nancy Madigan; A Scott Nielsen; Jacob A Sloane; Revere P Kinkel; Caterina Mainero
Journal:  Neuroimage Clin       Date:  2016-11-03       Impact factor: 4.881

8.  Contribution of Gray and White Matter Abnormalities to Cognitive Impairment in Multiple Sclerosis.

Authors:  Xiaofei Zhang; Fangfang Zhang; Dehui Huang; Lei Wu; Lin Ma; Hua Liu; Yujun Zhao; Shengyuan Yu; Jiong Shi
Journal:  Int J Mol Sci       Date:  2016-12-27       Impact factor: 5.923

9.  Correlation between cortical lesions and cognitive impairment in multiple sclerosis.

Authors:  Erica Curti; Stefania Graziuso; Elena Tsantes; Girolamo Crisi; Franco Granella
Journal:  Brain Behav       Date:  2018-04-21       Impact factor: 2.708

10.  Gray Matter Pathology in MS: Neuroimaging and Clinical Correlations.

Authors:  Justin Morris Honce
Journal:  Mult Scler Int       Date:  2013-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.